title: Conservative management of Gradenigo syndrome in a child.
abstract: Gradenigo syndrome consists of the association of otitis media, facial pain in regions innervated by the first and second division of trigeminal nerve and abducens nerve paralysis. It is caused by osteitis of the petrous apex (PA) and is a very rare complication of otitis media. Its treatment usually consists in mastoidectomy and antibiotics. We report a case of a 6-year-old child, which was managed medically with a positive outcome.
authors.affiliation: Department of Pediatric Otorhinolaryngology, Hôpital Necker-Enfants Malades, 11 avenue Franco-Russe, Paris 75007, France. remimarian@aol.com
authors.forename: R
authors.initials: R
authors.lastname: Marianowski
authors.forename: S
authors.initials: S
authors.lastname: Rocton
authors.forename: J L
authors.initials: JL
authors.lastname: Ait-Amer
authors.forename: M P
authors.initials: MP
authors.lastname: Morisseau-Durand
authors.forename: Y
authors.initials: Y
authors.lastname: Manach
mesh_terms: D020434:Abducens Nerve Diseases / Q000150:complications / Q000188:drug therapy*; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005157:Facial Pain / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010033:Otitis Media / Q000150:complications / Q000188:drug therapy*; D010579:Petrous Bone; D013577:Syndrome
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone